Evaluation of Pathologic Response in Lymph Nodes of Patients With Lung Cancer Receiving Neoadjuvant Chemotherapy

Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

(2020) Annikka Weissferdt et al.   Clinical Lung Cancer

IASLC MULTIDISCIPLINARY RECOMMENDATIONS FOR PATHOLOGIC ASSESSMENT OF LUNG CANCER RESECTION SPECIMENS FOLLOWING NEOADJUVANT THERAPY

(2020) William D. Travis et al.   Journal of Thoracic Oncology

Pan-Tumor Pathologic Scoring of Response to PD-(L)1 Blockade

(2019) Julie E Stein et al.   CLINICAL CANCER RESEARCH

Major pathologic response and RAD51 predict survival in lung cancer patients receiving neoadjuvant chemotherapy

(2018) Apar Pataer et al.   Cancer Medicine

Validation of the T descriptor in the new 8th TNM classification for non-small cell lung cancer

(2018) Hee Suk Jung et al.   Journal of Thoracic Disease

Current Status and Future Perspectives on Neoadjuvant Therapy in Lung Cancer

(2018) Gideon M. Blumenthal et al.   Journal of Thoracic Oncology

The Role of Neoadjuvant Trials in Drug Development for Solid Tumors

(2016) S. A. Funt et al.   CLINICAL CANCER RESEARCH

The 2015 World Health Organization Classification of Lung Tumors

(2015) William D. Travis et al.   Journal of Thoracic Oncology

Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint

(2014) Matthew D Hellmann et al.   LANCET ONCOLOGY

A Multifactorial Histopathologic Score for the Prediction of Prognosis of Resected Esophageal Adenocarcinomas After Neoadjuvant Chemotherapy

(2013) Rupert Langer et al.   ANNALS OF SURGICAL ONCOLOGY

Computed Tomography RECIST Assessment of Histopathologic Response and Prediction of Survival in Patients with Resectable Non–Small-Cell Lung Cancer after Neoadjuvant Chemotherapy

(2013) William N. William et al.   Journal of Thoracic Oncology

Proposal for a Multifactorial Prognostic Score That Accurately Classifies 3 Groups of Gastric Carcinoma Patients With Different Outcomes After Neoadjuvant Chemotherapy and Surgery

(2012) Karen Becker et al.   ANNALS OF SURGERY

Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy

(2012) Apar Pataer et al.   Journal of Thoracic Oncology

Survival Benefit of Neoadjuvant Chemotherapy in Non-small Cell Lung Cancer: An Updated Meta-Analysis of 13 Randomized Control Trials

(2010) Wei-An Song et al.   Journal of Thoracic Oncology

A Novel Histopathological Evaluation Method Predicting the Outcome of Non-small Cell Lung Cancer Treated by Neoadjuvant Therapy: The Prognostic Importance of the Area of Residual Tumor

(2010) Yuki Yamane et al.   Journal of Thoracic Oncology

Early changes in tumor size in patients treated for advanced stage nonsmall cell lung cancer do not correlate with survival

(2009) Katherine R. Birchard et al.   CANCER

Computed Tomography Response, But Not Positron Emission Tomography Scan Response, Predicts Survival After Neoadjuvant Chemotherapy for Resectable Non–Small-Cell Lung Cancer

(2008) Tawee Tanvetyanon et al.   JOURNAL OF CLINICAL ONCOLOGY